Table 1.
Patient characteristics between inoperable and operative groups.
| Characteristic | Operation | Inoperable | P value | Univariate | |
|---|---|---|---|---|---|
| (n = 74) | (n = 10) | Odds ratio (95% CI) | P value | ||
| Age | 0.001 | ||||
| ≤70 | 61 | 3 | Reference | ||
| >70 | 13 | 7 | 10.95 (2.495-48.054) | 0.002 | |
| Gender | 0.292 | ||||
| Male | 61 | 10 | Reference | ||
| Female | 13 | 0 | 1.000 | 0.993 | |
| T stage | 1.000 | ||||
| T1-2 | 4 | 0 | Reference | ||
| T3-4 | 69 | 10 | 1.000 | 0.994 | |
| N stage | 1.000 | ||||
| N0 | 3 | 0 | Reference | ||
| N1-2 | 70 | 10 | 1.000 | 0.995 | |
| Location | 0.540 | ||||
| Upper | 9 | 2 | Reference | ||
| Middle | 27 | 2 | 0.333 (0.041-2.722) | 0.305 | |
| Lower | 38 | 6 | 0.711 (0.123-4.120) | 0.703 | |
| Length of the lesion | 0.027 | ||||
| ≤6.75 cm | 58 | 4 | Reference | ||
| >6.75 cm | 16 | 6 | 5.438 (1.391-23.570) | 0.016 | |
| Chemotherapy | 0.323 | ||||
| Triweekly | 31 | 2 | Reference | ||
| Weekly | 41 | 8 | 1.000 | 0.180 | |
| Tegafur | 2 | 0 | 1.000 | 0.999 | |